Flaig Lab

Main Research Focus:
Genitourinary cancer translational research

Recent Publications 

1. Arthur C, Flaig T, Su L, Denney R, Barnes F, Glodé LM.  The effect of ultrasonic irradiation on doxorubicin-induced cytotoxicity in three human bladder cancer cell lines.  Ultrasonics.  2007; 46(1): 68-73.

2. Flaig TW, Nordeen SK, Lucia S, Harrison G, and Glodé LM.  Conference Report: Current status of biomarkers potentially associated with prostate cancer outcomes. Journal of Urology.  2007; 177(4):1229-37.

3. Flaig TW, Gustafson DL, Su L, Zirrolli J, Harrison G, Pierson AS, Agarwal R, Glodé LM.  A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer.  Investigational New Drugs.  2007; 25(2):139-46.

4. Flaig TW, Su Lih-Jen, Agarwal R, Glodé LM.  Silibinin synergizes with mitoxantrone to inhibit cell growth via apoptosis in prostate cancer cells.  International Journal of Cancer.  2007; 120(9): 2028-33. 

Lab Personnel

Thomas Flaig, MD - PI
Gail Harrison, PhD, - Senior Research Associate
Lih-Jen Su, MS - Senior PRA
Yuan Li, MD - Visiting Researcher